Tag Archives: World Health Organization

May, 2017

5 May
WHO to Begin Pilot Prequalification of Biosimilars for Cancer Treatment

4 MAY 2017 | GENEVA – This year WHO will launch a pilot project for prequalifying biosimilar medicines, a step towards making some of the most expensive treatments for cancer more widely available in low- and middle-income countries. In September, WHO will invite manufacturers to submit applications for prequalification of …
Share

15 January
Boehringer Ingelheim Inks $262 Million CNS Deal with Arena Pharmaceuticals

INGELHEIM, Germany, and SAN DIEGO, Jan. 12, 2016 /PRNewswire/ — Boehringer Ingelheim and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that they have signed an exclusive agreement to conduct joint research to identify drug candidates targeting an undisclosed G protein-coupled receptor (GPCR), which belongs to the group of orphan CNS …
Share

8 May
WHO Adds New Hep C Drugs to Essential List but Lower Prices are Needed for Patient Access

Today, the World Health Organization (WHO) updated its list of essential drugs, adding new key hepatitis C drugs, but said that prices need to be reduced in order to be accessible to patients in poorer countries. The agency added to the list of essential drugs five new direct acting oral …
Share

13 April
Hospira Outlines Importance of Biosimilars Having Same Nonproprietary Names as Original Biologics

At the World Health Organization (WHO) in Geneva, Switzerland, Hospira, Inc. said that it is essential for biosimilar drugs to be given the same nonproprietary names as original biologics. Hospira, the world’s leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, said that biosimilars should …
Share